Chemours Operating Cycle from 2010 to 2026

CC Stock  USD 20.52  0.10  0.49%   
Chemours' Operating Cycle is increasing over the years with slightly volatile fluctuation. Operating Cycle is expected to dwindle to 103.08. During the period from 2010 to 2026 Chemours Operating Cycle annual values regression line had geometric mean of  125.06 and mean square error of  185.68. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
148.16
Current Value
103.08
Quarterly Volatility
16.18871604
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Chemours financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemours' main balance sheet or income statement drivers, such as Depreciation And Amortization of 311.8 M, Interest Expense of 157.1 M or Selling General Administrative of 786.3 M, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.0433 or PTB Ratio of 8.14. Chemours financial statements analysis is a perfect complement when working with Chemours Valuation or Volatility modules.
  
Build AI portfolio with Chemours Stock
Check out the analysis of Chemours Correlation against competitors.
Analyzing Chemours's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing Chemours's current valuation and future prospects.

Latest Chemours' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Chemours Co over the last few years. It is Chemours' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemours' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Chemours Operating Cycle Regression Statistics

Arithmetic Mean126.00
Geometric Mean125.06
Coefficient Of Variation12.85
Mean Deviation12.59
Median125.37
Standard Deviation16.19
Sample Variance262.07
Range61.5459
R-Value0.58
Mean Square Error185.68
R-Squared0.34
Significance0.01
Slope1.86
Total Sum of Squares4,193

Chemours Operating Cycle History

2026 103.08
2025 148.16
2024 164.63
2023 140.04
2022 131.72
2021 122.23
2020 125.37

About Chemours Financial Statements

Chemours stakeholders use historical fundamental indicators, such as Chemours' Operating Cycle, to determine how well the company is positioned to perform in the future. Although Chemours investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemours' assets and liabilities are reflected in the revenues and expenses on Chemours' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemours Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 148.16  103.08 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Chemours Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Diversified Chemicals sector continue expanding? Could Chemours diversify its offerings? Factors like these will boost the valuation of Chemours. Projected growth potential of Chemours fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Chemours data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.65)
Dividend Share
0.675
Earnings Share
(2.13)
Revenue Per Share
38.893
Quarterly Revenue Growth
(0.01)
Understanding Chemours requires distinguishing between market price and book value, where the latter reflects Chemours's accounting equity. The concept of intrinsic value - what Chemours' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Chemours' price substantially above or below its fundamental value.
It's important to distinguish between Chemours' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemours should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Chemours' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.